Product Information
CLINDAMYCIN PHOS 1% PLEDGET is a generic product labeled by Carnegie Pharmaceuticals LLC, priced at $0.2854 per EA under NDC 80005013109. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Jun 13, 2025. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Carnegie Pharmaceuticals LLCNDC
80005013109
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA219612FDA Approved
6/13/2025
TE Code
AT
On Market Since
6/16/2025
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOS 1% PLEDGET has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2854 per EA |
|---|---|
| All-time high | $0.3145 (Oct 15, 2025) |
| All-time low | $0.2781 (Feb 18, 2026) |
| 52-week high | $0.3145 |
| 52-week low | $0.2781 |
| Median price | $0.2892 |
| Average price | $0.2924 |
| Largest weekly change | -4.9% (Dec 17, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clindamycin Phosphate Topical market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Carnegie Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate Topical market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOS 1% PLEDGET?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOS 1% PLEDGET, manufactured by Carnegie Pharmaceuticals LLC, is $0.2854 per EA (NDC 80005013109), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOS 1% PLEDGET changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOS 1% PLEDGET has declined 4.2%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOS 1% PLEDGET?
Since Aug 13, 2025, the NADAC for CLINDAMYCIN PHOS 1% PLEDGET has ranged from a low of $0.2781 (Feb 18, 2026) to a high of $0.3145 (Oct 15, 2025), with a median of $0.2892 per EA.
Are there cheaper alternatives to CLINDAMYCIN PHOS 1% PLEDGET?
No other NADAC-published product currently shares the active ingredient and strength of CLINDAMYCIN PHOS 1% PLEDGET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLINDAMYCIN PHOS 1% PLEDGET?
CLINDAMYCIN PHOS 1% PLEDGET (NDC 80005013109) is labeled by Carnegie Pharmaceuticals LLC, and CMS classifies it as a generic product.